Jacqueline Garcia, MD
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia (NCT07439211) | Jacqueline Garcia, MD | 2026-07-01 |
| A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax (NCT07148180) | Jacqueline Garcia, MD | 2026-02-02 |
| Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms (NCT05455294) | Jacqueline Garcia, MD | 2022-07-18 |
| Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN (NCT03613532) | Jacqueline Garcia, MD | 2018-10-24 |
Track Jacqueline Garcia, MD automatically
Every clearance here is in the API, with alerts when new ones post.